Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder

Acta Psychiatrica Scandinavica

Volumn 95, Issue 2, 1997, Pages 153-160

  Lecrubier, Y ^a   Judge, R ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

Clomipramine; Longitudinal study; Panic attacks; Panic disorder; Paroxetine

Indexed keywords

CLOMIPRAMINE; PAROXETINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEADACHE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PANIC; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; SWEATING; VERTIGO; WEIGHT GAIN; XEROSTOMIA;

EID: 0031055776     PISSN: 0001690X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0447.1997.tb00389.x     Document Type: Article

References (17)

1. ALEXANDER PE. Management of panic disorders. J Psychoact Drugs 1991: 23: 329-333.
2. BALLENGER JC. Medication discontinuation in panic disorder. J Clin Psychiatry 1992: 53 (Suppl. 3): 26-31.
3. AGRAS WS. The diagnosis and treatment of panic disorder. Annu Rev Med 1993: 44: 39-51.
4. BURROWS GD, JUDD FK, NORMAN TR. Long-term drug treatment of panic disorder. J Psychiatr Res 1993: 27 (Suppl. 1): 111-125.
5. ALEXANDER PE, ALEXANDER DD. Alprazolam treatment for panic disorders. J Clin Psychiatry 1986: 47: 301-304.
6. FONTAINE R, CHOUINARD G. Antipanic effect of clonazepam. Am J Psychiatry 1984: 141: 149.
7. ZITRIN CM, KLEIN DF, WOERNER MG. Treatment of agoraphobia with group exposure in vivo and imipramine. Arch Gen Psychiatry 1980: 37: 63-72.
8. GLOGER S, GRUNHAUS L, BIRMACHER B et al. Treatment of spontaneous panic attacks with clomipramine. Am J Psychiatry 1981: 138: 1215-1217.
9. CASSANO GB, PETRACCA A, PERUGI G et al. Clomipramine for panic disorder. I. The first 10 weeks of a long-term comparison with imipramine. J Affect Disord 1988: 14: 123-127.
10. DEN BOER JA, WESTENBERG HGM, KAMERBECK WDJ, VERHOEVEN WMA, KAHN RS. Effect of serotonin uptake inhibitors in anxiety disorders; a double-blind comparison of clomipramine and fluvoxamine. Int Clin Psychopharmacology 1987: 2: 21-32.
11. EVANS L, KENARDY J, SCHNEIDER P, HOEY H. Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. Acta Psychiatr Scand 1986: 73: 49-53.
12. BLACK DW, WESNER R, BOWERS W et al. A comparison of fluvoxamine, cognitive therapy, and placebo in the treatment of panic disorder. Arch Gen Psychiatry 1993: 50: 44-50.
13. HOEHN-SARIC R, MCLEOD DR, HIPSLEY PA. Effect of fluvoxamine in panic disorder. J Clin Psychopharmacology 1993: 13: 321-326.
14. LECRUBIER Y, BAKKER A, DUNBAR G, JUDGE R and the Collaborative Paroxetine Panic Study Investigators. A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Acta Psychiatr Scand 1997: 93: 145-152.
15. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, revised 3rd edn. Washington, DC: American Psychiatric Association, 1987.
16. SHEEHAN DV, BALLENGER JC, JACOBSEN G. Treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms. Arch Gen Psychiatry 1980: 37: 51-59.
17. OEHRBERG S, CHRISTIANSEN PE, BEHNKE K et al. Paroxetine in the treatment of panic disorder. A randomized, double-blind, placebo-controlled study. Br J Psychiatry 1995: 167: 374-379.